Define differences in the third-trimester fluid volume and variability between patients who develop superimposed preeclampsia (sPreE) and those that maintain chronic hypertension (cHTN).
Determine the diagnostic value of changes in fluid volume for diagnosing sPreE.
Determine feasibility and acceptability of fluid volume surveillance with a wearable device, GoBe2.
